How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
A selective aldosterone blocker approved for improving the survival of stable patients with left ventricular systolic dysfunction (ejection fraction below 40%) and clinical evidence of congestive heart failure after acute MI. The first member of this drug class approved for a heart failure indication. Approved last year for hypertension, alone or in combination with other agents.
* Recommended Dosage: 50 mg/day.
* Special Considerations: In...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
